Nanovibronix, Inc. (NASDAQ:FEED) Short Interest Update

Nanovibronix, Inc. (NASDAQ:FEED) was the target of a significant increase in short interest in June. As of June 15th, there was short interest totaling 409,683 shares, an increase of 546.8% from the May 31st total of 63,342 shares. Approximately 6.8% of the company’s stock are short sold. Based on an average trading volume of 2,865,952 shares, the short-interest ratio is currently 0.1 days.

Wall Street Analysts Forecast Growth

FEED has been the topic of a number of recent research reports. Weiss Ratings reiterated a “sell (e+)” rating on shares of Nanovibronix in a report on Friday, April 24th. Wall Street Zen upgraded shares of Nanovibronix from a “strong sell” rating to a “sell” rating in a report on Tuesday, April 28th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company presently has an average rating of “Sell”.

Nanovibronix Stock Up 2.4%

Nanovibronix stock traded up $0.01 during midday trading on Friday, hitting $0.58. 53,687 shares of the stock were exchanged, compared to its average volume of 6,852,107. The company has a market capitalization of $3.54 million, a PE ratio of -0.07 and a beta of 1.51. Nanovibronix has a 52-week low of $0.55 and a 52-week high of $17.40. The stock’s 50-day simple moving average is $1.03.

Nanovibronix (NASDAQ:FEED) last announced its earnings results on Monday, May 18th. The company reported ($6.88) earnings per share for the quarter. The business had revenue of $0.65 million during the quarter. Nanovibronix had a negative return on equity of 54.25% and a negative net margin of 923.20%.

Insider Transactions at Nanovibronix

In other Nanovibronix news, insider Christian Michael Glibert sold 210,000 shares of the firm’s stock in a transaction that occurred on Monday, June 22nd. The stock was sold at an average price of $0.69, for a total value of $144,900.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 1.40% of the company’s stock.

About Nanovibronix

Nanovibronix (NASDAQ: FEED) is a medical device company focused on the development and commercialization of non‑invasive therapeutic ultrasound technologies for clinical and consumer healthcare applications. The company’s product portfolio centers on wearable ultrasound devices designed to deliver low‑intensity acoustic energy to soft tissue with the objective of promoting wound healing and reducing pain. Nanovibronix positions its technology as an alternative or adjunct to conventional wound‑care and analgesic therapies, aiming to address chronic and acute conditions that are managed in both outpatient and home settings.

The company concentrates its commercial efforts on supplying hospitals, wound‑care clinics, long‑term care facilities and patients requiring home‑based therapies.